Free Hikma Pharmaceuticals Governance Journey Case Study Solution | Assignment Help

Harvard Case - Hikma Pharmaceuticals Governance Journey

"Hikma Pharmaceuticals Governance Journey" Harvard business case study is written by Lynn Sharp Paine, Suraj Srinivasan, Gamze Yucaoglu. It deals with the challenges in the field of General Management. The case study is 26 page(s) long and it was first published on : Feb 12, 2018

At Fern Fort University, we recommend Hikma Pharmaceuticals implement a comprehensive governance framework that prioritizes transparency, accountability, and stakeholder engagement. This framework should be built upon a robust set of principles, policies, and practices that align with international best practices and address the unique challenges of operating in a global pharmaceutical landscape.

2. Background

Hikma Pharmaceuticals, a multinational pharmaceutical company headquartered in Jordan, has experienced significant growth and expansion over the past few decades. This growth has brought new challenges, particularly in the area of corporate governance. The case study highlights Hikma's journey towards establishing a more robust governance structure, emphasizing the importance of adapting to evolving regulatory landscapes, fostering a culture of ethical behavior, and ensuring long-term sustainability.

The main protagonists in the case study are the company's leadership team, including the Board of Directors, CEO, and senior management, who are tasked with navigating the complex challenges of globalization, regulatory compliance, and stakeholder expectations.

3. Analysis of the Case Study

This case study can be analyzed through the lens of several frameworks, including:

  • Corporate Governance Framework: Hikma's journey demonstrates the importance of a comprehensive governance framework that encompasses board composition, board independence, executive compensation, shareholder rights, and ethical conduct.
  • Strategic Planning: Hikma's strategic planning process needs to be aligned with its governance framework, ensuring that growth strategies are balanced with ethical considerations and long-term sustainability.
  • Risk Assessment: The case highlights the need for a robust risk assessment process to identify and mitigate potential risks associated with international business operations, regulatory changes, and reputational damage.
  • Stakeholder Management: Hikma's success depends on managing relationships with a diverse range of stakeholders, including employees, investors, customers, regulators, and communities.
  • Change Management: Implementing significant changes to governance structures requires a well-defined change management process to ensure buy-in from all stakeholders, minimize resistance, and facilitate a smooth transition.

4. Recommendations

To strengthen Hikma's governance framework and ensure long-term sustainability, we recommend the following:

  • Establish a Clear Governance Structure: Define roles and responsibilities for the Board of Directors, management team, and key committees.
  • Enhance Board Independence: Increase the number of independent directors on the board, ensuring diverse perspectives and expertise.
  • Develop a Robust Code of Conduct: Implement a comprehensive code of conduct that outlines ethical principles and expectations for all employees.
  • Strengthen Risk Management Processes: Implement a robust risk management framework that identifies, assesses, and mitigates potential risks across all business operations.
  • Improve Transparency and Disclosure: Increase transparency in financial reporting, corporate governance practices, and stakeholder engagement.
  • Foster a Culture of Compliance: Create a culture where ethical behavior is valued and compliance is prioritized.
  • Invest in Technology and Analytics: Leverage technology and data analytics to enhance risk management, compliance monitoring, and decision-making.
  • Develop a Sustainability Strategy: Integrate environmental, social, and governance (ESG) considerations into business operations and report on sustainability performance.

5. Basis of Recommendations

These recommendations are based on the following considerations:

  • Core Competencies and Consistency with Mission: The recommendations align with Hikma's core competencies in pharmaceutical development and manufacturing, while also ensuring consistency with its mission of providing high-quality medicines to patients worldwide.
  • External Customers and Internal Clients: The recommendations prioritize the needs of external customers (patients and healthcare providers) and internal clients (employees and investors).
  • Competitors: The recommendations consider the competitive landscape in the pharmaceutical industry and aim to enhance Hikma's competitive advantage through improved governance and ethical practices.
  • Attractiveness ' Quantitative Measures: While it is difficult to quantify the impact of governance improvements on financial performance, the recommendations are expected to enhance investor confidence, reduce regulatory risk, and improve brand reputation, leading to long-term growth and profitability.
  • Assumptions: These recommendations assume that Hikma's leadership team is committed to implementing these changes and that the company has the resources and expertise to effectively execute the recommendations.

6. Conclusion

Hikma Pharmaceuticals has a strong foundation for continued success. By implementing a robust governance framework that prioritizes transparency, accountability, and stakeholder engagement, Hikma can further enhance its reputation, attract investors, and ensure long-term sustainability in a complex and competitive global market.

7. Discussion

Alternative approaches to strengthening governance could include:

  • Adopting a dual-class share structure: This could provide management with greater control over the company, but it could also raise concerns about shareholder rights and transparency.
  • Outsourcing certain governance functions: This could reduce costs and improve efficiency, but it could also lead to a loss of control over important aspects of the company.

The key risks associated with these recommendations include:

  • Resistance to change: Some stakeholders may resist changes to the governance structure, particularly if they perceive them as threatening their interests.
  • Cost of implementation: Implementing these recommendations will require significant investment in resources and expertise.
  • Unforeseen challenges: The global pharmaceutical landscape is constantly evolving, and Hikma may face unforeseen challenges that require adjustments to its governance framework.

8. Next Steps

To implement these recommendations, Hikma should take the following steps:

  • Form a governance task force: This task force should be composed of senior executives, independent directors, and other key stakeholders.
  • Develop a detailed implementation plan: This plan should outline specific actions, timelines, and resource requirements.
  • Communicate the changes to stakeholders: Hikma should communicate the rationale for the changes and the expected benefits to all stakeholders.
  • Monitor progress and make adjustments: Hikma should regularly monitor the progress of the implementation and make adjustments as needed.

By taking these steps, Hikma can ensure that its governance framework is robust, effective, and aligned with its long-term strategic goals.

Hire an expert to write custom solution for HBR General Management case study - Hikma Pharmaceuticals Governance Journey

Case Description

The case opens with Said Darwazah, chairman and CEO of Hikma Pharmaceuticals, the multinational generics company, anticipating the company's 2017 AGM and reflecting on changes made over the previous year to address concerns expressed by proxy advisors and some shareholders about Hikma's reliance on a combined chairman/CEO position, the long tenure of some directors, and the company's approach to executive pay. The case describes Hikma's origins as Jordanian pharma company founded by Darwazah's father in 1978, and traces the evolution of its governance as a private family company, then as publicly-traded company listed on the London Stock Exchange in 2005, and finally as a member of the FTSE 100, beginning in March 2015. Ahead of the 2017 AGM, Darwazah is confident that shareholders will approve changes made to the company's executive incentive plan (EIP) and steps taken to accelerate the turnover of long-serving directors, but he wonders how much longer the company will be able to continue with a combined Chairman/CEO and, more generally, how to marry the high level of governance expected by shareholders with the entrepreneurial spirit that had driven Hikma's growth and development.

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Write my custom case study solution for Harvard HBR case - Hikma Pharmaceuticals Governance Journey

Hire an expert to write custom solution for HBR General Management case study - Hikma Pharmaceuticals Governance Journey

Hikma Pharmaceuticals Governance Journey FAQ

What are the qualifications of the writers handling the "Hikma Pharmaceuticals Governance Journey" case study?

Our writers hold advanced degrees in their respective fields, including MBAs and PhDs from top universities. They have extensive experience in writing and analyzing complex case studies such as " Hikma Pharmaceuticals Governance Journey ", ensuring high-quality, academically rigorous solutions.

How do you ensure confidentiality and security in handling client information?

We prioritize confidentiality by using secure data encryption, access controls, and strict privacy policies. Apart from an email, we don't collect any information from the client. So there is almost zero risk of breach at our end. Our financial transactions are done by Paypal on their website so all your information is very secure.

What is Fern Fort Univeristy's process for quality control and proofreading in case study solutions?

The Hikma Pharmaceuticals Governance Journey case study solution undergoes a rigorous quality control process, including multiple rounds of proofreading and editing by experts. We ensure that the content is accurate, well-structured, and free from errors before delivery.

Where can I find free case studies solution for Harvard HBR Strategy Case Studies?

At Fern Fort University provides free case studies solutions for a variety of Harvard HBR case studies. The free solutions are written to build "Wikipedia of case studies on internet". Custom solution services are written based on specific requirements. If free solution helps you with your task then feel free to donate a cup of coffee.

I’m looking for Harvard Business Case Studies Solution for Hikma Pharmaceuticals Governance Journey. Where can I get it?

You can find the case study solution of the HBR case study "Hikma Pharmaceuticals Governance Journey" at Fern Fort University.

Can I Buy Case Study Solution for Hikma Pharmaceuticals Governance Journey & Seek Case Study Help at Fern Fort University?

Yes, you can order your custom case study solution for the Harvard business case - "Hikma Pharmaceuticals Governance Journey" at Fern Fort University. You can get a comprehensive solution tailored to your requirements.

Can I hire someone only to analyze my Hikma Pharmaceuticals Governance Journey solution? I have written it, and I want an expert to go through it.

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Pay an expert to write my HBR study solution for the case study - Hikma Pharmaceuticals Governance Journey

Where can I find a case analysis for Harvard Business School or HBR Cases?

You can find the case study solution of the HBR case study "Hikma Pharmaceuticals Governance Journey" at Fern Fort University.

Which are some of the all-time best Harvard Review Case Studies?

Some of our all time favorite case studies are -

Can I Pay Someone To Solve My Case Study - "Hikma Pharmaceuticals Governance Journey"?

Yes, you can pay experts at Fern Fort University to write a custom case study solution that meets all your professional and academic needs.

Do I have to upload case material for the case study Hikma Pharmaceuticals Governance Journey to buy a custom case study solution?

We recommend to upload your case study because Harvard HBR case studies are updated regularly. So for custom solutions it helps to refer to the same document. The uploading of specific case materials for Hikma Pharmaceuticals Governance Journey ensures that the custom solution is aligned precisely with your needs. This helps our experts to deliver the most accurate, latest, and relevant solution.

What is a Case Research Method? How can it be applied to the Hikma Pharmaceuticals Governance Journey case study?

The Case Research Method involves in-depth analysis of a situation, identifying key issues, and proposing strategic solutions. For "Hikma Pharmaceuticals Governance Journey" case study, this method would be applied by examining the case’s context, challenges, and opportunities to provide a robust solution that aligns with academic rigor.

"I’m Seeking Help with Case Studies,” How can Fern Fort University help me with my case study assignments?

Fern Fort University offers comprehensive case study solutions, including writing, analysis, and consulting services. Whether you need help with strategy formulation, problem-solving, or academic compliance, their experts are equipped to assist with your assignments.

Achieve academic excellence with Fern Fort University! 🌟 We offer custom essays, term papers, and Harvard HBR business case studies solutions crafted by top-tier experts. Experience tailored solutions, uncompromised quality, and timely delivery. Elevate your academic performance with our trusted and confidential services. Visit Fern Fort University today! #AcademicSuccess #CustomEssays #MBA #CaseStudies

How do you handle tight deadlines for case study solutions?

We are adept at managing tight deadlines by allocating sufficient resources and prioritizing urgent projects. Our team works efficiently without compromising quality, ensuring that even last-minute requests are delivered on time

What if I need revisions or edits after receiving the case study solution?

We offer free revisions to ensure complete client satisfaction. If any adjustments are needed, our team will work closely with you to refine the solution until it meets your expectations.

How do you ensure that the case study solution is plagiarism-free?

All our case study solutions are crafted from scratch and thoroughly checked using advanced plagiarism detection software. We guarantee 100% originality in every solution delivered

How do you handle references and citations in the case study solutions?

We follow strict academic standards for references and citations, ensuring that all sources are properly credited according to the required citation style (APA, MLA, Chicago, etc.).

Hire an expert to write custom solution for HBR General Management case study - Hikma Pharmaceuticals Governance Journey




Referrences & Bibliography for SWOT Analysis | SWOT Matrix | Strategic Management

1. Andrews, K. R. (1980). The concept of corporate strategy. Harvard Business Review, 61(3), 139-148.

2. Ansoff, H. I. (1957). Strategies for diversification. Harvard Business Review, 35(5), 113-124.

3. Brandenburger, A. M., & Nalebuff, B. J. (1995). The right game: Use game theory to shape strategy. Harvard Business Review, 73(4), 57-71.

4. Christensen, C. M., & Raynor, M. E. (2003). Why hard-nosed executives should care about management theory. Harvard Business Review, 81(9), 66-74.

5. Christensen, C. M., & Raynor, M. E. (2003). The innovator's solution: Creating and sustaining successful growth. Harvard Business Review Press.

6. D'Aveni, R. A. (1994). Hypercompetition: Managing the dynamics of strategic maneuvering. Harvard Business Review Press.

7. Ghemawat, P. (1991). Commitment: The dynamic of strategy. Harvard Business Review, 69(2), 78-91.

8. Ghemawat, P. (2002). Competition and business strategy in historical perspective. Business History Review, 76(1), 37-74.

9. Hamel, G., & Prahalad, C. K. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

10. Kaplan, R. S., & Norton, D. P. (1992). The balanced scorecard--measures that drive performance. Harvard Business Review, 70(1), 71-79.

11. Kim, W. C., & Mauborgne, R. (2004). Blue ocean strategy. Harvard Business Review, 82(10), 76-84.

12. Kotter, J. P. (1995). Leading change: Why transformation efforts fail. Harvard Business Review, 73(2), 59-67.

13. Mintzberg, H., Ahlstrand, B., & Lampel, J. (2008). Strategy safari: A guided tour through the wilds of strategic management. Harvard Business Press.

14. Porter, M. E. (1979). How competitive forces shape strategy. Harvard Business Review, 57(2), 137-145.

15. Porter, M. E. (1980). Competitive strategy: Techniques for analyzing industries and competitors. Simon and Schuster.

16. Porter, M. E. (1985). Competitive advantage: Creating and sustaining superior performance. Free Press.

17. Prahalad, C. K., & Hamel, G. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

18. Rumelt, R. P. (1979). Evaluation of strategy: Theory and models. Strategic Management Journal, 1(1), 107-126.

19. Rumelt, R. P. (1984). Towards a strategic theory of the firm. Competitive Strategic Management, 556-570.

20. Teece, D. J., Pisano, G., & Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509-533.